Arca
Skip to content
Tools
Tools

RYR3: Ryanodine receptor 3

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Cytosolic calcium-activated calcium channel that mediates the release of Ca(2+) from the sarcoplasmic reticulum into the cytoplasm in muscle and thereby plays a role in triggering muscle contraction.

  • Drugs that act on it: 1
  • With a US drug page: 1
  • Type: Protein

Drugs That Act on It

Approved and clinical-stage drugs ChEMBL records for this target; those with a US drug page link to it.
DrugUS approvalMechanismActionWarnings
DantroleneApprovedRyanodine receptor 3 antagonistAntagonistBoxed warning

Diseases Most Associated With It

Open Targets association score, 0 to 1; all associations
Congenital myopathy 20
0.61
Fever
0.52
Stroke disorder
0.43
Neurodegenerative disease
0.37
Nemaline myopathy
0.37
Malignant hyperthermia of anesthesia
0.37
Spasticity
0.37
Hydrops fetalis
0.34
Primary ovarian failure
0.31
Lobular capilliary hemangioma
0.29

Drugs and mechanisms are from ChEMBL CHEMBL2062 (CC BY-SA 3.0). Gene name, function (UniProt Q15413, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.